December 23, 2003: Baxter Announces Change to Fourth Quarter and Full-Year 2003 Earnings Guidance
December 18, 2003: National Hemophilia Foundation Announces Recipients of the NHF Grants Sponsored by Baxter
December 10, 2003: Baxter Awarded Multi-Year Contract by Veterans Hospitals as Exclusive Provider of Intravenous Solutions and Sets
December 9, 2003: Baxter Recognized by Institute for Safe Medication Practices for Infusion Pump Technology That Helps Reduce Risk of Medication Error
December 8, 2003: Data Analyses Further Support Safety and Efficacy of Baxter’s ADVATE for Hemophilia A
December 1, 2003: Baxter International Inc. Names Former Maytag Executive Vice President Carole Uhrich to Board of Directors
November 26, 2003: Baxter Announces Agreement to Move Into State-of-the-Art Biotechnology Center
November 19, 2003: Baxter Announces that Carlos del Salto Will Succeed Al Heller as President of Renal Business
November 18, 2003: Baxter Declares Annual Dividend
November 14, 2003: Baxter Announces the Launch of First-of-its-Kind Chronic
Kidney Disease Research Program to Develop a New Model of Renal Disease Care
November 13, 2003: New Data Published in Leading Nephrology Journal Suggest At-Home Dialysis an Effective Option for More Patients with Advanced Kidney Disease
November 10, 2003: Baxter Celebrates 50 Years as a Pioneer and Leader in the Biotechnology Industy
November 4, 2003: Baxter International Names Corporate Vice President of Global Quality Management
October 23, 2003: Advate Receives Unanimous Positive Opinion in Europe for the Treatment of Haemophilia A
October 20, 2003: Baxter Completes Acquisition of Aralast from Alpha Therapeutic Corporation
October 16, 2003: Baxter Reports Third Quarter Sales Growth of Nine Percent
October 14, 2003: Baxter Announces Launch of Syndeo Patient-Controlled Analgesia Syringe Pump
October 09, 2003: Baxter Confirms Advate Availability
September 30, 2003: Avecia Wins $71 Millions Anthrax Vaccines Contract
September 29, 2003: Baxter Awarded Contract from NIH for Development of SARS Vaccine
September 24, 2003: Baxter and Miltenyi Biotec Sign 5-Year Distribution Agreement for Cellular Therapy Products
September 22, 2003: Baxter International Inc. Names Chairman and CEO of
Wellmark Blue Cross Blue Shield to Board of Directors
September 18, 2003: Baxter Announces Pricing for Public Offering
September 18, 2003: Baxter Receives Notification of Multi-Year Contract Awards from Premier for Medication Delivery Products
September 16, 2003: Baxter Announces Public Offering of Common Stock
September 12, 2003: Baxter Announces U.S. Commercial Availability of ADVATE, Signs Multi-Year Agreements with Leading U.S. Specialty Pharmacy Customers
September 4 , 2003: Baxter and Cerus Halt Red Blood Cell Clinical Trials for Investigational Pathogen Inactivation System
July 29, 2003: Federal Court Dismisses Shareholder Suit Against Baxter and Its Officers
July 29, 2003: Baxter Highlights Economic, Social and Environmental Performance in Its Fourth Annual Sustainability Report
July 25, 2003: FDA Approves Baxter´s ADVATE for the Treatment of Hemophilia A
July 17, 2003: Baxter to Cooperate with Information Request from SEC
July 17, 2003: Baxter´s Sales Grow 11 Percent in Second Quarter
July 10, 2003: Baxter Healthcare Agrees to Sale of Renal Services Components
July 2, 2003: Baxter Announces Several Actions to Improve Profitability and Return on Assets
June 24, 2003: Baxter Receives 510K Clearance from U.S. FDA for ARENA, an Innovative Hemodialysis Device
June 23, 2003: Baxter Receives FDA Approval for PREMASOL Sulfite-free (Amino Acid) Injections
June 4, 2003: Baxter Expanding Its Contract Manufacturing Services to Better Serve Its Pharmaceutical and Biotechnology Clients
June 3, 2003: Baxter and Cerus Reach Agreement with FDA on Steps to Gain Regulatory Approval for Innovative Pathogen Inactivation System
May 30, 2003: Baxter Announces Launch of Aralast™ for Patients with Hereditary Emphysema in Need of New Therapy
May 21, 2003: Baxter and GlycoFi to Collaborate on Development of New Platform for Manufacturing of Human Therapeutic Proteins
May 6, 2003: Shareholders Approve Proposals on Director Elections, Auditor Appointment and Incentive Compensation Plan at Baxter´s Annual Meeting
May 6, 2003: Baxter Launches New Automated Blood Component Collection System
May 6, 2003: Baxter´s Newest Peritoneal Dialysis Solution -- EXTRANEAL (Icodextrin) -- Approved for Sale in Japan
May 5, 2003: Baxter Receives 510(k) Approval for EXELTRA, New Single-Use Dialyzer for Kidney Disease
April 16, 2003: Baxter Achieves First Quarter Sales and EPS Goals
March 28, 2003: Baxter and International Society of Nephrology Announce Renal Discoveries Grant Program Winners
March 27, 2003: Baxter Launches IV Products with ENLIGHTENEDHRBC Bar Coding System, Which Providies Expanded Information
March 20, 2003: Baxter to Acquire Manufacturing Plant from ML Laboratories
March 18, 2003: Delta State University´s Volunteer Program Receives $60,965 Grant from The Baxter International Foundation
March 18, 2003: Newly Published Data in Blood Confirm the Therapeutic Efficacy and Safety of INTERCEPT Platelets
March 13, 2003: Baxter Revises Sales Growth and Earnings Expectations for First Quarter and Full Year 2003
March 6, 2003: Mayo Clinic to Advance Xenotransplantation Research with Grant from Baxter
March 5, 2003: Baxter Provides Grant to Blood Banking and Transfusion Medicine Experts to Advance Awareness of Factors Contributing to Recent Observations of Aggregation in Collected Blood
March 4, 2003: New Data Suggest At-Home Dialysis Therapy an Effective Option for More Patients with Advanced Kidney Disease
March 4, 2003: Baxter and Arriva Pharmaceuticals Begin Clinical Trails for Recombinant Alpha 1-Antitrypsin
March 4, 2003: Davis Street Community Center Receives $50,000 Grant From The Baxter International Foundation
February 25, 2003: Baxter International Inc. Names Morehouse School of Medicine President to Board of Directors
February 19, 2003: IU-Bloomington Center on Aging and Community Receives $94,000 Grant From Baxter International Foundation
February 13, 2003: HealthReach Receives $31,000 Baxter International Foundation Grant to Open a Second Clinic in Lake County
February 11, 2003: National Survey Suggests Most Americans Remain Unaware That Dietary Fiber Can Help Maintain Healthy Hearts
February 05, 2003: Chippewa Valley Health Clinic Receives $20,000 Baxter International Foundation Grant
February 04, 2003: Hauora o Puketapapa to Hire an Outreach Nurse with US$34,000 Baxter International Foundation Grant
February 04, 2003: Baxter Introduces Advate As Brand Name For Its Investigational Hemophilia A Therapy
February 03, 2003: Baxter Continues Investigation Into American Red Cross Blood Pack Units
January 23, 2003: John C. Lincoln Health Network in Phoenix Wins Foster G. McGaw Prize for Excellence in Community Service
January 22, 2003: Baxter´s Sales and Earnings Grow in 2002
January 20, 2003: Baxter and Cerus Announce the First Customers for the Intercept Blood System
January 09, 2003: Alpha Therapeutic Corporation Receives FDA Approval for Aralast (TM) Alpha-1 Proteinase Inhibitor
Print this page
